Compare AI-suggested treatment plans for Grace Karimu
| Parameter |
Amlodipine
5mg once daily
|
Lisinopril
10mg once daily
|
Hydrochlorothiazide
25mg once daily
|
|---|---|---|---|
| Drug Class | CCB | ACE Inhibitor | Thiazide Diuretic |
| Efficacy Score |
88%
|
82%
|
74%
|
| Side Effects | Peripheral edema, flushing, dizziness | Dry cough, hyperkalemia, dizziness | Hypokalemia, hyperuricemia, photosensitivity |
| Contraindications | Severe aortic stenosis, cardiogenic shock | Bilateral renal artery stenosis, pregnancy, angioedema | Anuria, severe renal impairment, sulfonamide allergy |
| Dosage | 5mg PO once daily, may increase to 10mg | 10mg PO once daily, may titrate to 40mg | 25mg PO once daily, max 50mg |
Based on JNC-8 guidelines and SPRINT trial data. Amlodipine demonstrated superior systolic BP reduction in the ALLHAT trial for patients with metabolic syndrome.
Metformin 500mg interaction check completed. No significant drug-drug interactions identified with any of the three proposed antihypertensive agents.
AI model predicts 78% probability of achieving target BP (<130/80 mmHg) within 8 weeks with Amlodipine monotherapy. Combination therapy may be required.